Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05174351 · ClinicalTrials.gov registry record · NA

Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction

A NA study of Heart Failure With Preserved Ejection Fraction, sponsored by UConn Health.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05174351 is a NA study of Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by UConn Health. The registered enrollment target is 30 participants, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05174351, a NA study of Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by UConn Health.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.

Interventions

  • OTHER beta blocker discontinuation

Study Locations (1)

Connecticut

  • UConn Health / John Dempsey Hospital - Farmington

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-12-20
Est. Completion 2027-11-01
Phase NA

Sponsor

UConn Health

178 total trials

What the Registry Record Tells You About NCT05174351

The ClinicalTrials.gov registry entry for NCT05174351 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which beta blocker discontinuation is the first listed.

NCT05174351 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05174351 about?

NCT05174351 is a clinical study titled "Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction". This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.

What is the current status of trial NCT05174351?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-12-20. Estimated completion is 2027-11-01.

What conditions does trial NCT05174351 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT05174351?

The interventions under investigation include: beta blocker discontinuation (OTHER).

Who is sponsoring clinical trial NCT05174351?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05174351 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.